Abstract
IN addition to the well known antiviral action1 interferon preparations exert various biological effects on cells (for references see refs 2 and 3). While investigating the effect of interferon on the growth and development of newborn mice, we found that daily injection of potent mouse interferon preparations resulted in extensive liver cell degeneration and death between days 8 and 14 (ref. 4). When interferon treatment, begun at birth, was stopped between days 6 and 8 of life, liver cell damage appeared to be reversible and most mice recovered. In the ensuing months, several of these mice died and although the liver and other organs appeared normal, the kidneys were pale and the surface was granular. Histological examination revealed a severe glomerulonephritis. We report here an investigation of this phenomenon.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Isaacs, A., and Lindenmann, J., Proc. R. Soc., B 147, 258–267 (1957).
Gresser, I., Brouty-Boyé, D., Thomas, M. T., and Macieira-Coelho, A., Proc. natn. Acad. Sci. U.S.A., 66, 1052–1058 (1970).
Lindahl, P., Leary, P., and Gresser, I., Proc. natn. Acad. Sci. U.S.A., 70, 2785–2788 (1973).
Gresser, I., Tovey, M. G., Maury, C., and Chouroulinkov, I., Nature, 258, 76–78 (1975).
Tovey, M., Begon-Lours, J., and Gresser, I., Proc. Soc. exp. Biol. Med., 146, 809–815 (1974).
Gresser, I., Bandu, M. T., and Brouty-Boyé, D., J. natn. Cancer Inst., 52, 553–559 (1974).
Cantell, K., Hirvonen, S., Mogensen, K. E., and Pyhälä, L., In Vitro, Monog. No. 3 (edit. by Waymouth, C.), 35–38 (Tissue Culture Ass., Rockville, Maryland, 1974).
Oldstone, M. B. A., and Dixon, F. J., J. Immun., 106, 1260–1263 (1971).
Oldstone, M. B. A., and Dixon, F. J., J. Immun., 105, 829–837 (1970).
Baron, S., Buckler, C. E., McCloskey, R. V., and Kirschstein, R. L., J. Immun., 96, 12–16 (1966).
Subrahmanyan, T. P., and Mims, C. A., Br. J. exp. Path., 47, 168–176 (1966).
Gresser, I., Fontaine, D., Coppey, J., Falcoff, R., and Falcoff, E., Proc. Soc. exp. Biol. Med., 124, 91–94 (1967).
Ho, M., in Interferons and Interferon Inducers (edit. by Finter, N.), 241–249 (North-Holland, Amsterdam and London; American Elsevier, New York, 1973).
Sakaguchi, H., Dachs, S., Mautner, W., and Grishman, E., Lab. Invest., 13, 1418–1426 (1964).
Dixon, F., Harvey Lectures, 58, 21–52 (1963).
McCluskey, R. T., Vassalli, P., Gallo, G., and Baldwin, D. S., New Engl. J. Med., 274, 695–701 (1966).
McCluskey, R. T., in Pathology of the kidney, 1 (edit. by Heptinstall, R. H.), 273 (Little Brown, Boston, 1974).
Germuth, F. G., and Rodriguez, E., Immunopathology of the Renal Glomerulus (Little Brown, Boston, 1973).
Wilson, C. B., and Dixon, F. J., A. Rev. Med., 25, 83–98 (1974).
Tonietti, G., Oldstone, M. B. A., and Dixon, F. J., J. exp. Med., 132, 89–109 (1970).
Oldstone, M. B. A., and Dixon, F. J., J. exp. Med., 134, 32s–40s (1971).
Oldstone, M. B. A., Prog. med. Virol., 19, 84–119 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
GRESSER, I., MAURY, C., TOVEY, M. et al. Progressive glomerulonephritis in mice treated with interferon preparations at birth. Nature 263, 420–422 (1976). https://doi.org/10.1038/263420a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/263420a0
This article is cited by
-
A Brief Historical Perspective on the Pathological Consequences of Excessive Type I Interferon Exposure In vivo
Journal of Clinical Immunology (2018)
-
Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling
Nature Genetics (2014)
-
Dendritic cells and the immunopathogenesis of systemic lupus erythematosus
Immunologic Research (2007)
-
Dermatomyositis after interferon alpha treatment
Medical Oncology (2000)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
